Anastasia Sarikidi
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.
Journal: JAMA neurology
Published: January 10, 2022
SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia.
Journal: Journal of neurology
Published: March 05, 2020
Isoform-selective as opposed to complete depletion of fibroblast growth factor 2 (FGF-2) has no major impact on survival and gene expression in SOD1G93A amyotrophic lateral sclerosis mice.
Journal: The European journal of neuroscience
Published: October 29, 2018
Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
Journal: Journal of tissue engineering and regenerative medicine
Published: July 25, 2018
Characterizing the multiple roles of FGF-2 in SOD1G93A ALS mice in vivo and in vitro.
Journal: Journal of cellular physiology
Published: May 29, 2018
Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: August 30, 2017
McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity.
Journal: International journal of molecular sciences
Published: July 28, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026